Sattva Neelapu
Regular Member
Professor
The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma
My team is interested in developing novel CAR T cell therapy approaches against novel targets and also develop allogeneic CAR T cells that can resist immune rejection and translate them to the clinic.
Education & Training
MD, Jawaharlal Institute of Post-Graduate Medical Education and Research, 1991